Abhishesh Kumar Mehata
M. Pharm., Ph.D. (Biomaterials, Drug Delivery, Targeted Therapy, Diagnosis, Cancer Biology, and Preclinical Testing) from IIT (BHU), India
M. Pharm., Ph.D. (Biomaterials, Drug Delivery, Targeted Therapy, Diagnosis, Cancer Biology, and Preclinical Testing) from IIT (BHU), India
My doctoral research project has centered on the “Development of targeted nanomedicine and nanotheranostics for breast cancer imaging and therapy.” Throughout my Ph.D. journey, I have gained a comprehensive range of technical and research skills. My area of expertise and interest includes the development of novel formulations for drug delivery, imaging, cancer biology, and theranostics, but is not limited to their in vitro characterization and in vivo evaluation in animal models, statistical analysis, and bioanalytical HPLC method development. I have extensive experience in the development of Polymeric NPs, Liquid crystal NPs, Solid lipid NPs, Liposomes, Cubosomes, Exosomes, Metallic NPs (Ag, Au, Ag-Au, Cus, etc.,) and ultrasmall fluorescent nanoclusters. I have hands-on experience in handling experimental animals such as mice, rats, guinea pigs, etc., and in the development of breast tumors and lung tumors by carcinogenic and syngeneic methods.
PLGA Nanoplatform for the Hypoxic Tumor Delivery: Folate Targeting, Therapy, and Ultrasound/Photoacoustic Imaging. Mehata et al, 2024, ACS Applied Bio materials.